Anti-Inflammatory and Longevity Benefits Emerging research shows that GLP-1 agonists may have anti-inflammatory effects independent of their metabolic actions
The effects of GLP-1RAs on multiple human organizations, source: reference [2] Data from Novo Nordisk's Phase III clinical trial showed that liraglutide 3.0 mg resulted in a 5% weight loss in approximately 62% of obese patients and a 10% weight loss in 34% of patients after a 56-week treatment period
The statements presented on this site have not been reviewed or approved by the United States Food and Drug Administration (FDA)
The full implications for this have yet to be assessed
All authors drafted the manuscript, participated in data analyses and interpretation, and revisions of the manuscript and approved the final version
Their receptors are just more sensitive, said coauthor Adriana Hung, M.D., M.P.H., a nephrologist and epidemiologist at Vanderbilt